Seeking the “holy grail” of biomarkers to improve stroke risk prediction of clinical scores
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Biomarkers are defined as “objective indications of medical state observed from outside the patient—which can be measured accurately and reproducibly.”1 Biomarkers have 3 major potential roles in clinical practice: (1) to help the patient understand their risk of disease, which could lead to direct improvement of quality of life; (2) to direct the patient to make lifestyle changes that could improve health, such as restricting or improving dietary choices, becoming more active, and adhering to a plan laid out in collaboration with their physician; and (3) to direct a medical professional to make a (better) clinical decision based on known risk factors or disease(s) associated with a specific biomarker(s).2 Given the complex pathophysiology of ischemic stroke, biomarkers that can stratify risk and identify those individuals most likely to have a cerebrovascular event are considered the “holy grail” of prognostic tools.
Footnotes
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the editorial.
See page 1206
- © 2016 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Babak Hooshmand and Dr. David Smith
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Article
Circulating biomarkers and incident ischemic stroke in the Framingham Offspring StudyAshkan Shoamanesh, Sarah R. Preis, Alexa S. Beiser et al.Neurology, August 24, 2016 -
Article
Lipid and lipoprotein measurements and the risk of ischemic vascular eventsFramingham StudyAleksandra Pikula, Alexa S. Beiser, Jing Wang et al.Neurology, January 07, 2015 -
Article
Association of Circulating Metabolites in Plasma or Serum and Risk of StrokeMeta-analysis From 7 Prospective CohortsDina Vojinovic, Marita Kalaoja, Stella Trompet et al.Neurology, December 02, 2020 -
Article
Shared genetic susceptibility of vascular-related biomarkers with ischemic and recurrent strokeStephen R. Williams, Fang-Chi Hsu, Keith L. Keene et al.Neurology, December 30, 2015